Consun Pharmaceutical Group Limited (1681.HK)
Manufactures traditional Chinese medicine and contrast agent drugs sold in mainland China.
13.53+0.02%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.4%
The outlook
Consun Pharmaceutical trades at 13.53, sitting well below its 50- and 200-day moving averages and near the lower end of its 52-week range. Analyst coverage shows an average price target roughly 76% above the current level, though the overall StockGlow score leans bearish. The stock carries a trailing P/E of 9.3.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range17% of the way from its 52-week low to high
Price targetAvg target +76% vs current price
Analyst price target
~12-month · 3 analysts23.77average target+75.7% vs now
Now 13.53
Low 21.60High 26.61
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$11.35B
52-wk high
19.35
52-wk low
12.31
50-day avg
13.72
200-day avg
15.62
Trailing P/E
9.3